- Home
- PEPG vs VNRX Comparison
PEPG vs VNRX Comparison
Compare PEPG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- VNRX
- Stock Information
- Founded
- PEPG 2018
- VNRX N/A
- Country
- PEPG United States
- VNRX United States
- Employees
- PEPG N/A
- VNRX N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PEPG Health Care
- VNRX Health Care
- Exchange
- PEPG Nasdaq
- VNRX Nasdaq
- Market Cap
- PEPG 64.2M
- VNRX 56.5M
- IPO Year
- PEPG 2022
- VNRX N/A
- Fundamental
- Price
- PEPG $1.37
- VNRX $0.55
- Analyst Decision
- PEPG Buy
- VNRX Strong Buy
- Analyst Count
- PEPG 3
- VNRX 4
- Target Price
- PEPG $14.67
- VNRX $4.17
- AVG Volume (30 Days)
- PEPG 486.5K
- VNRX 103.1K
- Earning Date
- PEPG 03-05-2025
- VNRX 03-24-2025
- Dividend Yield
- PEPG N/A
- VNRX N/A
- EPS Growth
- PEPG N/A
- VNRX N/A
- EPS
- PEPG N/A
- VNRX N/A
- Revenue
- PEPG N/A
- VNRX $1,285,827.00
- Revenue This Year
- PEPG N/A
- VNRX $71,446.31
- Revenue Next Year
- PEPG N/A
- VNRX N/A
- P/E Ratio
- PEPG N/A
- VNRX N/A
- Revenue Growth
- PEPG N/A
- VNRX 97.50
- 52 Week Low
- PEPG $1.16
- VNRX $0.43
- 52 Week High
- PEPG $19.30
- VNRX $1.10
- Technical
- Relative Strength Index (RSI)
- PEPG 31.82
- VNRX 41.65
- Support Level
- PEPG $1.16
- VNRX $0.56
- Resistance Level
- PEPG $1.60
- VNRX $0.61
- Average True Range (ATR)
- PEPG 0.14
- VNRX 0.04
- MACD
- PEPG 0.11
- VNRX -0.00
- Stochastic Oscillator
- PEPG 48.28
- VNRX 2.67
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.